Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer.
Pizarro G, Pinto MP, Muñoz-Medel M, Cordova-Delgado M, Bravo ML, Nervi B, Sánchez C, Ibañez C, Peña J, Walbaum B, Madrid J, Briones J, Koch E, Valbuena J, Gonzalez S, Gejman R, Acevedo F, Mondaca S, Garrido M, Vines E, Galindo H. Pizarro G, et al. Among authors: walbaum b. Clin Lung Cancer. 2020 Jul;21(4):e250-e254. doi: 10.1016/j.cllc.2020.01.012. Epub 2020 Jan 27. Clin Lung Cancer. 2020. PMID: 32088114 No abstract available.
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution.
Walbaum B, Acevedo F, Medina L, Bravo ML, Merino T, Camus M, Dominguez F, Mondaca S, Galindo H, Nervi B, Ibañez C, Madrid J, Peña J, Koch E, Garrido M, Pinto MP, Sánchez C. Walbaum B, et al. Curr Med Res Opin. 2020 Jul;36(7):1195-1199. doi: 10.1080/03007995.2020.1763282. Epub 2020 May 14. Curr Med Res Opin. 2020. PMID: 32351137
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.
Walbaum B, Acevedo F, Medina L, Bravo ML, Merino T, Camus M, Dominguez F, Mondaca S, Galindo H, Nervi B, Ibañez C, Madrid J, Muñiz S, Peña J, Koch É, Garrido M, Pinto MP, Sánchez C. Walbaum B, et al. Ecancermedicalscience. 2021 Feb 1;15:1178. doi: 10.3332/ecancer.2021.1178. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777171 Free PMC article.
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
Walbaum B, Puschel K, Medina L, Merino T, Camus M, Razmilic D, Navarro ME, Dominguez F, Cordova-Delgado M, Pinto MP, Acevedo F, Sánchez C. Walbaum B, et al. Breast Cancer Res Treat. 2021 Sep;189(2):561-569. doi: 10.1007/s10549-021-06317-1. Epub 2021 Jul 10. Breast Cancer Res Treat. 2021. PMID: 34244869
Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study.
Mondaca S, Walbaum B, Le Corre N, Ferrés M, Valdés A, Martínez-Valdebenito C, Ruiz-Tagle C, Macanas-Pirard P, Ross P, Cisternas B, Pérez P, Cabrera O, Cerda V, Ormazábal I, Barrera A, Prado ME, Venegas MI, Palma S, Broekhuizen R, Kalergis AM, Bueno SM, Espinoza MA, Balcells ME, Nervi B. Mondaca S, et al. Among authors: walbaum b. Vaccines (Basel). 2023 Jul 3;11(7):1193. doi: 10.3390/vaccines11071193. Vaccines (Basel). 2023. PMID: 37515009 Free PMC article.
Better overall survival in patients who achieve pathological complete response after neoadjuvant chemotherapy for breast cancer in a Chilean public hospital.
Acevedo F, Petric M, Walbaum B, Robin J, Legorburu L, Murature G, Guerra C, Navarro M, Canovas MJ, Sanchez C, Vargas L, Manzor M, Peña J, Muñiz S, Veglia P, Cartes R, Martinez R. Acevedo F, et al. Among authors: walbaum b. Ecancermedicalscience. 2021 Feb 11;15:1185. doi: 10.3332/ecancer.2021.1185. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777178 Free PMC article.
Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer.
Canteros D, Walbaum B, Córdova-Delgado M, Torrealba A, Reyes C, Navarro ME, Razmilic D, Camus M, Dominguez F, Navarrete O, Pinto MP, Pizarro G, Acevedo F, Sánchez C. Canteros D, et al. Among authors: walbaum b. Ecancermedicalscience. 2022 May 23;16:1396. doi: 10.3332/ecancer.2022.1396. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35919242 Free PMC article.
19 results